AGP Limited (PSX:AGP)

Market Cap	53.80B
Revenue (ttm)	26.11B
Net Income (ttm)	3.36B
Shares Out	280.00M
EPS (ttm)	12.00
PE Ratio	16.01
Forward PE	14.05
Dividend	4.00 (2.05%)
Ex-Dividend Date	Sep 2, 2025

Volume	356,532
Average Volume	242,269
Open	197.99
Previous Close	194.77
Day's Range	192.00 - 199.00
52-Week Range	120.00 - 220.02
Beta	0.29
RSI	43.20
Earnings Date	Oct 29, 2025

About AGP Limited

AGP Limited manufactures, sells, wholesales, distributes, exports, imports, markets, deals in pharmaceutical and healthcare products in Pakistan and Afghanistan. The company offers products in the areas of aminoglycosides, angiotensin II antagonist, anti-epileptics, anti-gout, anti-infective antidiarrheal, anti-inflammatory enzyme, antidiarrheal microorganisms, antifibrinolytic, antihistamines systemic, antileuk anti-ashtm sys, antineoplastic agent, anti-obesity, antirheumatic non-steroid, antispasmodic and anticholinergic plain, atypical antip...

• Industry: Pharmaceuticals
• Sector: Healthcare
• Founded: 1989
• Employees: 2,143
• Stock Exchange: Pakistan Stock Exchange
• Ticker Symbol: AGP

Financial Performance

In 2024, AGP Limited's revenue was 25.03 billion, an increase of 33.56% compared to the previous year's 18.74 billion. Earnings were 2.67 billion, an increase of 70.58%.